Spatial Genomics & Transcriptomics Market by Product (Instrument, Consumable, Service), Technique (Transcriptomics [IHC, ISH, RNA Sequencing], Genomics [LCM]), Service Type (Sample Prep, Analytical), Application (Drug Discovery) - Global Forecast to 2031

Market Size
$0.67B
MARKET SIZE, 2026
Projected Market Size
$1.23B
MARKET SIZE, 2031
CAGR
12.9%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, SHARE & GROWTH SNAPSHOT

spatial-genomics-transcriptomics-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global spatial genomics & transcriptomics market is projected to grow from USD 0.67 billion in 2026 to USD 1.23 billion by 2031, at a CAGR of 12.9% during the forecast period. The market was valued at USD 0.60 billion in 2025. The market is driven by increasing adoption of spatial profiling technologies, rising demand for high-resolution gene expression analysis, and expanding applications in translational research, oncology, precision medicine, and drug discovery. Wider use of spatial transcriptomics platforms, in situ hybridization technologies, and sequencing-based workflows is supporting molecular analysis while preserving tissue architecture. Additionally, growing interest in cellular heterogeneity, biomarker discovery, multi-omics integration, and AI-enabled spatial data interpretation is boosting demand for instruments, consumables, software, and spatial genomics and transcriptomics services across the market.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 0.60 Billion
    Current Market Size (2026): USD 0.67 Billion
    Forecast Market Size (2031): USD 1.23 Billion
    CAGR (2026–2031): 12.9%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America accounted for a 48.5% share of the spatial genomics & transcriptomics market in 2025.
    Offering Leader: Products held an 83.4% share of the market in 2025.
    Technique Leader: Spatial transcriptomics held a 70.0% share of the market for products in 2025.
    Type Leader: Sequencing & analytical services captured a 46.0% share of the market for services in 2025.
    Application Leader: Translational research captured a 71.5% market share in 2025.
    End User Leader (Products): Academic & research institutes accounted for a 64.1% share of the market for products in 2025.
    End User Leader (Services): Academic & research institutes captured a 54.9% share of the market for services in 2025.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Illumina, Inc. (US), 10x Genomics (US), and Bruker (US) were identified as some of the star players in the spatial genomics & transcriptomics market, given their strong market share and offering footprint.
    Precision Cell Systems (US), BioSpyder, Inc. (US), and Spatial Genomics (US), among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The spatial genomics & transcriptomics market is expanding due to increasing adoption of spatial profiling technologies, growing demand for high-resolution gene expression analysis, and advances in sequencing, imaging, and bioinformatics. Applications in translational research, oncology, precision medicine, and drug discovery are further supporting market growth.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The spatial genomics & transcriptomics market is shifting from conventional, bulk tissue-based assays toward high-throughput, integrated, and spatially resolved molecular profiling platforms. Adoption of next-generation sequencing (NGS)-based spatial transcriptomics, high-plex imaging-based spatial genomics, single-cell spatial multi-omics, subcellular resolution profiling, and spatial barcoding assays is increasing, enabling deeper insights into cellular architecture, tumor microenvironments, disease progression, and therapeutic response. Additionally, the growing demand for low-input FFPE sample compatibility, high-sensitivity probe panels, validated reagent kits, and standardized image-processing and bioinformatic QC workflows is accelerating market growth. Furthermore, integration of spatial genomics and transcriptomics with single-cell sequencing, multi-omics, and AI-driven image and data interpretation is improving biomarker discovery, patient stratification, and translational evidence generation, while outsourced spatial profiling services are supporting faster turnaround and broader adoption across drug discovery, translational research, and precision medicine applications.

spatial-genomics-transcriptomics-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising adoption of spatial genomics and transcriptomics in drug discovery and development
  • Introduction of novel spatial genomics and transcriptomics products
RESTRAINTS
Impact
Level
  • High initial capital investments and maintenance costs
  • High data complexity and computational requirements
OPPORTUNITIES
Impact
Level
  • Increasing use of spatial omics for biomarker identification
  • Mounting demand for precision medicines and targeted drug development
CHALLENGES
Impact
Level
  • Lack of standardization and reproducibility across spatial technologies

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising adoption of spatial genomics and transcriptomics in drug discovery and development

Increasing use of spatial genomics and transcriptomics in drug discovery is driven by the need to understand gene expression within tissue architecture and cellular interactions. These technologies support target identification, biomarker discovery, and evaluation of treatment responses. Integration with single-cell analysis, sequencing, and multi-omics workflows enables deeper biological insights, supports patient stratification, and improves the efficiency of preclinical research and therapeutic development.

Restraint: High initial capital investments and maintenance costs

Spatial genomics and transcriptomics technologies often require substantial investment in specialized instruments, assay kits, consumables, and computational infrastructure. Additional costs associated with sample preparation, data storage, software, and technical expertise can limit adoption among smaller laboratories and research institutions. The complexity of spatial workflows and the need for ongoing platform maintenance may further constrain implementation in resource-limited settings.

Opportunity: Increasing use of spatial omics for biomarker identification

Growing use of spatial profiling in biomarker discovery is creating opportunities across oncology, immunology, neuroscience, and precision medicine. These technologies enable researchers to examine gene expression alongside tissue organization and cellular interactions, supporting the identification and validation of disease-associated biomarkers. Expanding applications in patient stratification, therapeutic response assessment, and translational research are expected to increase demand for spatial assays, analytical software, and related services.

Challenge: Lack of standardization and reproducibility across spatial technologies

Variability in sample preparation, tissue preservation, assay protocols, detection sensitivity, and data analysis remains a major challenge for spatial genomics and transcriptomics. Differences across platforms can affect data comparability, reproducibility, and validation of biological findings. The complexity of integrating spatial datasets with sequencing and other molecular profiling results further increases analytical requirements, highlighting the need for standardized workflows, validated protocols, and reliable quality-control procedures.

SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Visium and Xenium platforms enable spatial gene expression analysis in intact tissues for oncology research, cellular mapping, biomarker discovery, and tissue heterogeneity studies. Enables high-resolution spatial profiling | Supports cellular and tissue-level analysis | Facilitates biomarker discovery and translational research
company logo
The CosMx Spatial Molecular Imager enables high-plex spatial RNA analysis to investigate cellular interactions, tumor microenvironments, and gene expression in oncology, neuroscience, and immunology. Enables detailed spatial gene expression analysis | Preserves tissue architecture | Supports investigation of cellular interactions and disease mechanisms
company logo
Sequencing platforms and reagents support sequencing-based spatial transcriptomics workflows for tissue profiling, disease research, biomarker discovery, and translational studies. Supports high-throughput sequencing and downstream spatial data analysis | Enables gene expression profiling | Facilitates integration of spatial transcriptomics with broader genomic research

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The spatial genomics & transcriptomics ecosystem comprises product manufacturers, service providers, end users, and regulatory authorities. Product manufacturers, including 10x Genomics (US), Illumina, Inc. (US), and Bruker (US), support the market by supplying spatial analysis platforms, sequencing technologies, assay kits, probes, reagents, consumables, and associated software used in spatial gene expression profiling and tissue analysis. Service providers such as Bio-Techne (US), Macrogen (South Korea), and BGI (China) support research workflows through molecular analysis, sequencing, sample processing, and related genomics services. Regulatory authorities, including the US FDA, the European Medicines Agency (EMA), and the UK's Medicines and Healthcare products Regulatory Agency (MHRA), provide relevant oversight for applicable clinical and diagnostic uses, while research applications are also subject to institutional ethics and data-protection requirements. End users, including the Broad Institute (US), Massachusetts Institute of Technology (US), pharmaceutical and biotechnology companies, academic research institutes, and clinical research organizations, use spatial genomics and transcriptomics technologies for oncology research, biomarker discovery, drug development, precision medicine, neuroscience, immunology, and translational research.

spatial-genomics-transcriptomics-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

spatial-genomics-transcriptomics-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Spatial Genomics & Transcriptomics Market, By Offering

In 2025, products dominated the spatial genomics & transcriptomics market. This dominance is driven by the widespread use of instruments, assay kits, probes, reagents, and consumables in spatial gene expression analysis and tissue characterization. These products are routinely used in oncology research, biomarker discovery, drug development, and translational studies. Their recurring use in spatial profiling workflows and continuous advances in high-resolution analysis technologies support sustained demand across academic, pharmaceutical, and biotechnology research settings.

Spatial Genomics & Transcriptomics Products Market, By Technique

In 2025, spatial transcriptomics dominated the spatial genomics & transcriptomics products market. This dominance is driven by its ability to map gene expression within intact tissue samples while preserving spatial context. Spatial transcriptomics products enable researchers to investigate tissue heterogeneity, cellular interactions, and molecular patterns associated with disease. Their increasing use in oncology, neuroscience, biomarker discovery, and drug development supports demand for spatial analysis instruments, assay kits, and related consumables.

Spatial Genomics & Transcriptomics Services Market, By Type

In 2025, sequencing & analytical services dominated the spatial genomics & transcriptomics services market. This dominance is driven by the need to generate and process high-quality spatial molecular data for gene expression analysis and tissue characterization. These services help researchers investigate cellular heterogeneity, spatial gene expression patterns, and interactions within complex biological environments. Their increasing use in oncology research, biomarker discovery, drug development, and translational studies supports demand from pharmaceutical companies, biotechnology firms, and academic research institutions.

Spatial Genomics & Transcriptomics Market, By Application

In 2025, translational research dominated the spatial genomics & transcriptomics market. This dominance is supported by the growing use of spatial profiling to connect molecular findings with disease biology and potential clinical applications. Spatial technologies enable researchers to investigate tissue heterogeneity, cellular interactions, gene expression patterns, and biomarker distribution. Increasing applications in therapeutic target identification, patient stratification, and treatment-response studies continue to drive demand across pharmaceutical development and clinical research.

Spatial Genomics & Transcriptomics Market Products, By End User

In 2025, academic and research institutes dominated the spatial genomics & transcriptomics products market. This dominance is driven by the extensive use of spatial profiling instruments, assay kits, and consumables in basic and translational research. These institutions apply spatial technologies to investigate gene expression, tissue organization, cellular interactions, and disease mechanisms across oncology, neuroscience, immunology, and developmental biology. Growing research funding and increasing adoption of high-resolution spatial analysis platforms continue to support product demand across academic and research settings.

Spatial Genomics & Transcriptomics Services Market, By End User

In 2025, academic & research institutes dominated the spatial genomics & transcriptomics services market. This dominance is driven by extensive basic and translational research in oncology, neuroscience, immunology, and developmental biology. These institutions increasingly use external spatial profiling services to investigate gene expression within intact tissues, characterize cellular interactions, and understand disease mechanisms. Collaborations with specialized service providers and the need for advanced analytical capabilities support demand for outsourced spatial genomics and transcriptomics services.

SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX

The spatial genomics & transcriptomics market company evaluation matrix highlights 10x Genomics (US) as a star due to its established sequencing capabilities and expanding spatial transcriptomics portfolio. The company supports spatial gene expression analysis through sequencing technologies and data analysis solutions, strengthening its position in spatial research. Takara Holdings Inc. (Japan) is classified as an emerging player following its expansion into spatial transcriptomics through the acquisition of Curio Bioscience in 2025. Curio’s spatial profiling technologies complement Takara Bio’s sequencing portfolio and strengthen its presence in spatial biology.

spatial-genomics-transcriptomics-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 0.60 Billion
Market Forecast in 2026 (Value) USD 0.67 Billion
Market Forecast in 2031 (Value) USD 1.23 Billion
Growth Rate CAGR of 12.9% from 2026-2031
Years Considered 2023-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Million/Billion), Volume (Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offering: Products and Services
  • By Technique (Products):
    • Spatial Transcriptomics
    • and Spatial Genomics
  • By Type (Services):
    • Sample Preparation Services
    • Sequencing & Analytical Services
    • and Data Visualization & Analysis Services
  • By Application: Translational Research and Drug Discovery & Development
  • By End User (Products):
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • CROs & CDMOs
    • and Clinical Diagnostic Laboratories
  • By End User (Services):
    • Pharmaceutical & Biopharmaceutical Companies
    • Academic & Research Institutes
    • and Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

WHAT IS IN IT FOR YOU: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET REPORT CONTENT GUIDE

spatial-genomics-transcriptomics-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Rest of Europe Breakdown Country-level market sizing and growth forecasts (Switzerland, Sweden, Turkey, the Netherlands, Norway, Poland, Portugal, Romania, Denmark, Estonia, Finland, the Czech Republic, Greece, Austria, Belgium, and Russia) Provides granular country-level insights, enabling clients to prioritize high-growth markets
Company Evaluation
  • Detailed analysis and profiling of top six market players
  • Portfolio assessment of top six companies
Delivers visibility into competitors, helping clients identify partners, evaluate positioning, and detect market gaps for smarter collaboration, outsourcing, and strategic market entry decisions

RECENT DEVELOPMENTS

  • April 2026 : 10x Genomics launched Atera, a new in situ spatial biology platform that provides whole-transcriptome spatial analysis at single-cell resolution within intact tissues. Introduced at AACR 2026, Atera targets high-plex spatial transcriptomics applications.
  • June 2025 : Illumina launched the StrataMap Spatial Solution, a sequencing-based spatial whole-transcriptome research platform that provides single-cell resolution. This solution enables unbiased spatial transcriptomics profiling across tissues, supporting discovery research and expanding Illumina’s presence in the spatial genomics & transcriptomics market.
  • February 2025 : Bio-Rad acquired Stilla Technologies, a French company specializing in high-precision genetic analysis systems based on digital PCR, in a transaction valued at approximately USD 225 million. This acquisition enhances Bio-Rad’s ddPCR technology base and supports multiomic and spatial genomics workflows.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
41
2
EXECUTIVE SUMMARY
 
 
 
 
 
46
3
PREMIUM INSIGHTS
 
 
 
 
 
52
2026
VS. 2031 (%)
 
 
 
 
 
54
4
MARKET OVERVIEW
Spatial omics revolutionizes drug discovery, driving precision medicine despite high costs and complexity.
 
 
 
 
 
55
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING ADOPTION OF SPATIAL GENOMICS & TRANSCRIPTOMICS IN DRUG DISCOVERY AND DEVELOPMENT
 
 
 
 
 
 
4.2.1.2
INTRODUCTION OF NOVEL SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS
 
 
 
 
 
 
4.2.1.3
INCREASING PHARMACEUTICAL R&D INVESTMENTS AND PUBLIC-PRIVATE FUNDING
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH INITIAL CAPITAL INVESTMENTS AND MAINTENANCE COSTS
 
 
 
 
 
 
4.2.2.2
HIGH DATA COMPLEXITY AND COMPUTATIONAL REQUIREMENTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
INCREASING USE OF SPATIAL OMICS FOR BIOMARKER IDENTIFICATION
 
 
 
 
 
 
4.2.3.2
INCREASING DEMAND FOR PRECISION MEDICINES AND TARGETED DRUG DEVELOPMENT
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
LACK OF STANDARDIZATION AND REPRODUCIBILITY ACROSS SPATIAL TECHNOLOGIES
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate shifting market dynamics with strategic insights from competitive forces and pricing trends.
 
 
 
 
 
65
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
THREAT FROM SUBSTITUTES
 
 
 
 
 
 
5.1.5
THREAT FROM NEW ENTRANTS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
 
 
 
 
 
 
5.2.4
TRENDS IN GLOBAL BIOTECH INDUSTRY
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
ROLE OF PLAYERS IN ECOSYSTEM
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023–2025
 
 
 
 
 
 
 
5.5.1.1
INSTRUMENTS
 
 
 
 
 
 
5.5.1.2
CONSUMABLES
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 9027)
 
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 9027)
 
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.9
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
 
HIGH-RESOLUTION SPATIAL TRANSCRIPTOMICS CHARACTERIZES
 
 
 
 
 
 
5.10.2
COSMX WHOLE-TRANSCRIPTOME IMAGING REVEALS MOLECULAR HETEROGENEITY IN KIDNEY CANCER
 
 
 
 
 
 
5.10.3
INTEGRATED SPATIAL GENOMICS & TRANSCRIPTOMICS REVEAL GENOME ORGANIZATION IN BREAST CANCER
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFFS—SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.5.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.11.5.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
5.11.5.3
CROS & CDMOS
 
 
 
 
 
 
5.11.5.4
CLINICAL DIAGNOSTIC LABORATORIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations revolutionize spatial genomics, boosting patent filings and market potential.
 
 
 
 
 
87
 
6.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
6.1.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1.1
IN SITU SEQUENCING
 
 
 
 
 
 
6.1.1.2
IN SITU HYBRIDIZATION
 
 
 
 
 
 
6.1.1.3
SPATIAL BARCODING AND SEQUENCING
 
 
 
 
 
6.1.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.2.1
TISSUE IMAGING AND HISTOPATHOLOGICAL ANALYSIS
 
 
 
 
 
 
6.1.2.2
SPATIAL HEATMAP
 
 
 
 
 
 
6.1.2.3
DIFFERENTIAL GENE EXPRESSION ANALYSIS
 
 
 
 
 
6.1.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.1.3.1
MULTI-OMICS
 
 
 
 
 
 
6.1.3.2
METABOLOMICS
 
 
 
 
 
 
6.1.3.3
SINGLE-CELL ANALYSIS
 
 
 
 
6.2
TECHNOLOGY ROADMAP
 
 
 
 
 
 
6.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.3.1
METHODOLOGY
 
 
 
 
 
 
6.3.2
NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
 
 
 
 
 
 
6.3.3
LIST OF KEY PATENTS
 
 
 
 
 
6.4
FUTURE APPLICATIONS
 
 
 
 
 
 
6.5
IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
 
 
 
 
 
 
 
 
6.5.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.5.2
BEST PRACTICES IN AI-ENABLED SPATIAL GENOMICS & TRANSCRIPTOMICS WORKFLOWS
 
 
 
 
 
 
6.5.3
CASE STUDIES OF AI IMPLEMENTATION IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
 
 
 
 
 
 
6.5.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.5.5
CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SPATIAL GENOMICS & TRANSCRIPTOMICS TECHNOLOGIES
 
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate complex regulations to drive sustainability through strategic compliance and eco-certification insights.
 
 
 
 
 
98
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Uncover pivotal buyer criteria and stakeholder influence shaping industry purchasing decisions.
 
 
 
 
 
105
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
KEY BUYING CRITERIA, BY END USER (PRODUCT)
 
 
 
 
 
 
8.2.3
KEY BUYING CRITERIA, BY END USER (SERVICES)
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
9
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Units | 123 Data Tables
 
 
 
 
 
110
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PRODUCTS
 
 
 
 
 
 
 
9.2.1
INSTRUMENTS & SOFTWARE
 
 
 
 
 
 
 
9.2.1.1
INSTRUMENTS & SOFTWARE TO FACILITATE DISEASE RESEARCH BY ENABLING DETAILED SPATIAL MAPPING AND MULTI-OMIC ANALYSES
 
 
 
 
 
9.2.2
CONSUMABLES
 
 
 
 
 
 
 
9.2.2.1
BETTER REPRODUCIBLE AND HIGH-QUALITY DATA COLLECTION TO ADVANCE SPATIAL GENOMICS RESEARCH IN ONCOLOGY AND PRECISION MEDICINE
 
 
 
 
9.3
SERVICES
 
 
 
 
 
 
 
9.3.1
INCREASING DEMAND FOR HIGH-QUALITY SPATIAL DATA IN PRECISION MEDICINE TO AUGMENT MARKET GROWTH
 
 
 
 
 
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,
 
 
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
SPATIAL TRANSCRIPTOMICS
 
 
 
 
 
 
 
10.2.1
IMMUNOHISTOCHEMISTRY
 
 
 
 
 
 
 
10.2.1.1
INCREASING APPLICATIONS IN BIOMARKER DISCOVERY AND CELLULAR INTERACTIONS WITHIN TISSUE ARCHITECTURE TO DRIVE SEGMENT
 
 
 
 
 
10.2.2
RNA SEQUENCING
 
 
 
 
 
 
 
10.2.2.1
IN SITU RNA SEQUENCING
 
 
 
 
 
 
 
 
10.2.2.1.1
INTEGRATION OF ISS WITH BIOINFORMATICS TOOLKITS FOR DATA ANALYSIS TO FACILITATE INTERPRETATION OF COMPLEX DATASETS
 
 
 
 
10.2.2.2
SINGLE-CELL RNA SEQUENCING
 
 
 
 
 
 
 
 
10.2.2.2.1
INCREASING COMMERCIAL AVAILABILITY OF SCRNA-SEQ PLATFORMS AND ADVANCEMENTS IN BIOINFORMATICS TOOLS TO DRIVE SEGMENT
 
 
 
 
10.2.2.3
OTHER RNA SEQUENCING
 
 
 
 
 
10.2.3
IN SITU HYBRIDIZATION
 
 
 
 
 
 
 
10.2.3.1
HIGH-THROUGHPUT AND 3D SPATIAL GENE EXPRESSION ANALYSIS IN CANCER RESEARCH AND DEVELOPMENTAL BIOLOGY TO DRIVE SEGMENT
 
 
 
 
 
10.2.4
MICROSCOPY-BASED RNA IMAGING
 
 
 
 
 
 
 
10.2.4.1
BETTER INSIGHTS INTO MOLECULAR COMMUNICATION WITHIN TISSUE ARCHITECTURE TO AUGMENT SEGMENT GROWTH
 
 
 
 
 
10.2.5
IMMUNOFLUORESCENCE
 
 
 
 
 
 
 
10.2.5.1
ADVANCED PROFILING OF IMMUNE-TUMOR MICROENVIRONMENTS FOR CANCER DIAGNOSIS AND PROGNOSIS TO PROPEL SEGMENT GROWTH
 
 
 
 
 
10.2.6
LASER CAPTURE MICRODISSECTION
 
 
 
 
 
 
 
10.2.6.1
ANALYSIS OF GENE EXPRESSION DATA FROM DEFINED CELLULAR POPULATIONS TO FACILITATE SPATIAL MAPPING WITHIN TISSUE SECTIONS
 
 
 
 
 
10.2.7
OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
 
 
 
 
 
10.3
SPATIAL GENOMICS
 
 
 
 
 
 
 
10.3.1
IN SITU HYBRIDIZATION
 
 
 
 
 
 
 
10.3.1.1
DEMAND FOR HIGH-SPECIFICITY DETECTION PLATFORMS TO FUEL MARKET GROWTH
 
 
 
 
 
10.3.2
LASER CAPTURE MICRODISSECTION
 
 
 
 
 
 
 
10.3.2.1
DETAILED INSIGHTS INTO CELLULAR MECHANISMS AND MOLECULAR PROFILES WITHIN HETEROGENEOUS TISSUE SAMPLES TO DRIVE SEGMENT
 
 
 
 
 
10.3.3
GENOMIC SEQUENCING
 
 
 
 
 
 
 
10.3.3.1
MICRODISSECTION-BASED SEQUENCING
 
 
 
 
 
 
 
 
10.3.3.1.1
INCREASED DEMAND FOR PRECISION MEDICINES TO BOOST SEGMENT GROWTH
 
 
 
 
10.3.3.2
CHROMATIN ACCESSIBILITY SEQUENCING
 
 
 
 
 
 
 
 
10.3.3.2.1
NEED FOR INSIGHTS INTO GENE REGULATION AND EPIGENETIC MODIFICATIONS TO AID SEGMENT GROWTH
 
 
 
 
10.3.3.3
OTHER GENOMIC SEQUENCING
 
 
 
 
 
10.3.4
OTHER SPATIAL GENOMICS TECHNIQUES
 
 
 
 
11
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 16 Data Tables
 
 
 
 
 
178
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
SAMPLE PREPARATION SERVICES
 
 
 
 
 
 
 
11.2.1
NEED FOR ACCURATE SPATIAL ANALYSIS OF GENE EXPRESSION WITHIN TISSUE SAMPLES TO SPUR MARKET GROWTH
 
 
 
 
 
11.3
SEQUENCING & ANALYTICAL SERVICES
 
 
 
 
 
 
 
11.3.1
SEQUENCING & ANALYTICAL SERVICES TO UTILIZE ADVANCED TECHNOLOGIES FOR SEQUENCING AND BIOINFORMATICS ANALYSIS
 
 
 
 
 
11.4
DATA VISUALIZATION & ANALYSIS SERVICES
 
 
 
 
 
 
 
11.4.1
INCREASED DEMAND FOR ADVANCED TOOLS FOR COMPLEX SPATIAL GENOMICS DATA INTERPRETATION TO SUPPORT MARKET GROWTH
 
 
 
 
12
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 58 Data Tables
 
 
 
 
 
188
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
TRANSLATIONAL RESEARCH
 
 
 
 
 
 
 
12.2.1
CANCER
 
 
 
 
 
 
 
12.2.1.1
SPATIAL GENOMICS AND TRANSCRIPTOMICS TO MAP PRECISE LOCATIONS OF DNA AND RNA WITHIN TUMOR TISSUES IN CANCER RESEARCH
 
 
 
 
 
12.2.2
IMMUNOLOGY
 
 
 
 
 
 
 
12.2.2.1
NEED FOR BETTER UNDERSTANDING OF IMMUNE CELL INTERACTIONS AND TISSUE-SPECIFIC IMMUNE RESPONSES TO PROPEL SEGMENT GROWTH
 
 
 
 
 
12.2.3
NEUROSCIENCE
 
 
 
 
 
 
 
12.2.3.1
INCREASED FOCUS ON MAPPING CELLULAR DIVERSITY FOR ANALYZING BRAIN FUNCTION AND DYSFUNCTION TO AID MARKET GROWTH
 
 
 
 
 
12.2.4
INFECTIOUS DISEASES
 
 
 
 
 
 
 
12.2.4.1
NEED FOR ENHANCED UNDERSTANDING OF PATHOGEN-HOST INTERACTIONS AT TISSUE LEVEL TO DRIVE ADOPTION
 
 
 
 
 
12.2.5
OTHER DISEASES
 
 
 
 
 
12.3
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
 
 
12.3.1
RISING USE OF RNA-SEQ IN DISEASE MANAGEMENT AND DRUG DISCOVERY TO DRIVE MARKET
 
 
 
 
 
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET
 
 
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
13.2.1
FOCUS ON FOUNDATIONAL DISCOVERIES AND CELLULAR INSIGHTS ABOUT COMPLEX BIOLOGICAL SYSTEMS TO AID MARKET GROWTH
 
 
 
 
 
13.3
CROS & CDMOS
 
 
 
 
 
 
 
13.3.1
GROWING DEMAND FOR PRECISE SPATIAL MOLECULAR INSIGHTS TO PROPEL MARKET GROWTH
 
 
 
 
 
13.4
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
13.4.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO TRANSFORM DISEASE RESEARCH AND STREAMLINE DRUG TARGET VALIDATION
 
 
 
 
 
13.5
CLINICAL DIAGNOSTIC LABORATORIES
 
 
 
 
 
 
 
13.5.1
IMPROVED DIAGNOSTIC ACCURACY IN PATHOGEN DETECTION AND GENOMIC ANALYSIS TO AID MARKET GROWTH
 
 
 
 
14
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 16 Data Tables
 
 
 
 
 
223
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
14.2.1
NEED FOR TOOLS FOR MAPPING CELLULAR ENVIRONMENTS AND STUDYING DISEASE MECHANISMS TO PROPEL MARKET GROWTH
 
 
 
 
 
14.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
14.3.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO OPTIMIZE BIOMARKER DEVELOPMENT AND IMPROVE CLINICAL TRIAL DESIGN
 
 
 
 
 
14.4
OTHER END USERS
 
 
 
 
 
15
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION
Comprehensive coverage of 6 Regions with country-level deep-dive of 14 Countries | 286 Data Tables.
 
 
 
 
 
234
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
NORTH AMERICA
 
 
 
 
 
 
 
15.2.1
US
 
 
 
 
 
 
 
15.2.1.1
US TO DOMINATE NORTH AMERICAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DURING FORECAST PERIOD
 
 
 
 
 
15.2.2
CANADA
 
 
 
 
 
 
 
15.2.2.1
FAVORABLE GOVERNMENT INITIATIVES AND HIGH INCIDENCE OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH
 
 
 
 
15.3
EUROPE
 
 
 
 
 
 
 
15.3.1
GERMANY
 
 
 
 
 
 
 
15.3.1.1
ADVANCED GENOMICS RESEARCH AND PRESENCE OF SEVERAL KEY COMPANIES TO SPUR MARKET GROWTH
 
 
 
 
 
15.3.2
UK
 
 
 
 
 
 
 
15.3.2.1
INCREASING GOVERNMENT FUNDING AND RISING DEMAND FOR NEW DIAGNOSTIC BIOMARKERS TO AID MARKET GROWTH
 
 
 
 
 
15.3.3
FRANCE
 
 
 
 
 
 
 
15.3.3.1
INCREASING INVESTMENTS IN LIFE SCIENCE R&D AND RISING NUMBER OF BIOTECH COMPANIES TO PROPEL MARKET GROWTH
 
 
 
 
 
15.3.4
ITALY
 
 
 
 
 
 
 
15.3.4.1
INCREASING FOCUS ON DISEASE RESEARCH AND EXPANDING DIAGNOSTIC CAPABILITIES TO AUGMENT MARKET GROWTH
 
 
 
 
 
15.3.5
SPAIN
 
 
 
 
 
 
 
15.3.5.1
FOCUS ON ADVANCED CANCER RESEARCH AND INCREASED NEED FOR PERSONALIZED MEDICINES TO PROPEL MARKET GROWTH
 
 
 
 
 
15.3.6
REST OF EUROPE
 
 
 
 
 
15.4
ASIA PACIFIC
 
 
 
 
 
 
 
15.4.1
CHINA
 
 
 
 
 
 
 
15.4.1.1
ADVANCING DOMESTIC SPATIAL TECHNOLOGIES AND AI-ENABLED DATA ANALYSIS ARE STRENGTHENING SPATIAL BIOLOGY RESEARCH
 
 
 
 
 
15.4.2
JAPAN
 
 
 
 
 
 
 
15.4.2.1
STRATEGIC ACQUISITIONS AND INTEGRATED SPATIAL WORKFLOWS ARE ACCELERATING TECHNOLOGY ADOPTION
 
 
 
 
 
15.4.3
INDIA
 
 
 
 
 
 
 
15.4.3.1
EXPANDING GENOMICS RESEARCH AND PRECISION ONCOLOGY ARE CREATING OPPORTUNITIES FOR SPATIAL ANALYSIS TECHNOLOGIES
 
 
 
 
 
15.4.4
SOUTH KOREA
 
 
 
 
 
 
 
15.4.4.1
BIOTECHNOLOGY INVESTMENT AND RESEARCH ACCESS PROGRAMS ARE SUPPORTING SPATIAL TRANSCRIPTOMICS ADOPTION
 
 
 
 
 
15.4.5
AUSTRALIA
 
 
 
 
 
 
 
15.4.5.1
RESEARCH INFRASTRUCTURE AND INDUSTRY PARTNERSHIPS ARE EXPANDING ACCESS TO SPATIAL OMICS TECHNOLOGIES
 
 
 
 
 
15.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
15.5
LATIN AMERICA
 
 
 
 
 
 
 
15.5.1
BRAZIL
 
 
 
 
 
 
 
15.5.1.1
NATIONAL GENOMICS INITIATIVES AND PRECISION PUBLIC HEALTH ARE CREATING PATHWAYS FOR SPATIAL TRANSCRIPTOMICS ADOPTION
 
 
 
 
 
15.5.2
MEXICO
 
 
 
 
 
 
 
15.5.2.1
STRENGTHENING GENOMIC RESEARCH INFRASTRUCTURE AND COMPUTATIONAL EXPERTISE IS SUPPORTING SPATIAL BIOLOGY OPPORTUNITIES
 
 
 
 
 
15.5.3
REST OF LATIN AMERICA
 
 
 
 
 
15.6
MIDDLE EAST
 
 
 
 
 
 
15.7
AFRICA
 
 
 
 
 
16
COMPETITIVE LANDSCAPE
Uncover key strategies and market dominance of top players and emerging startups.
 
 
 
 
 
346
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
 
 
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS,
 
 
 
 
 
16.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
 
 
16.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
16.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
16.5.1
STARS
 
 
 
 
 
 
16.5.2
EMERGING LEADERS
 
 
 
 
 
 
16.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
16.5.4
PARTICIPANTS
 
 
 
 
 
 
16.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
16.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
16.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
16.5.5.3
OFFERING FOOTPRINT
 
 
 
 
 
 
16.5.5.4
TECHNIQUE FOOTPRINT
 
 
 
 
 
 
16.5.5.5
APPLICATION FOOTPRINT
 
 
 
 
16.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
16.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
16.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
16.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
16.6.4
STARTING BLOCKS
 
 
 
 
 
 
16.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
16.6.5.1
DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
16.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
16.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
 
16.7.1
COMPANY VALUATION
 
 
 
 
 
 
16.7.2
COMPANY VALUATION
 
 
 
 
 
16.8
BRAND COMPARISON
 
 
 
 
 
 
 
16.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
16.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
16.9.2
DEALS
 
 
 
 
 
 
16.9.3
EXPANSIONS
 
 
 
 
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
366
 
17.1
KEY PLAYERS
 
 
 
 
 
 
 
17.1.1
10X GENOMICS
 
 
 
 
 
 
 
17.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
17.1.1.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
17.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
17.1.1.3.1
PRODUCT/SERVICE LAUNCHES
 
 
 
 
 
 
17.1.1.3.2
DEALS
 
 
 
 
 
 
17.1.1.3.3
EXPANSIONS
 
 
 
 
17.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
17.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
17.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
17.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
17.1.2
BIO-TECHNE
 
 
 
 
 
 
17.1.3
BRUKER
 
 
 
 
 
 
17.1.4
STANDARD BIOTOOLS INC.
 
 
 
 
 
 
17.1.5
ILLUMINA, INC.
 
 
 
 
 
 
17.1.6
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
 
17.1.7
VISIOPHARM A/S
 
 
 
 
 
 
17.1.8
DANAHER CORPORATION
 
 
 
 
 
 
17.1.9
VELSERA INC.
 
 
 
 
 
 
17.1.10
REVVITY, INC.
 
 
 
 
 
 
17.1.11
VIZGEN, INC.
 
 
 
 
 
 
17.1.12
TAKARA HOLDINGS INC.
 
 
 
 
 
 
17.1.13
BGI GENOMICS CO., LTD.
 
 
 
 
 
 
17.1.14
MACROGEN, INC.
 
 
 
 
 
 
17.1.15
MILTENYI BIOTEC
 
 
 
 
 
17.2
OTHER PLAYERS
 
 
 
 
 
 
 
17.2.1
BIOMARKER TECHNOLOGIES (BMKGENE)
 
 
 
 
 
 
17.2.2
PRECISION CELL SYSTEMS, INC.
 
 
 
 
 
 
17.2.3
ADMERA HEALTH
 
 
 
 
 
 
17.2.4
SONY BIOTECHNOLOGY INC.
 
 
 
 
 
 
17.2.5
CANTATA BIO
 
 
 
 
 
 
17.2.6
NUCLEAI, INC.
 
 
 
 
 
 
17.2.7
COMPLETE GENOMICS INCORPORATED
 
 
 
 
 
 
17.2.8
BIOSPYDER, INC.
 
 
 
 
 
 
17.2.9
SINGULAR GENOMICS SYSTEMS, INC.
 
 
 
 
 
 
17.2.10
REBUS BIOSYSTEMS, INC.
 
 
 
 
 
 
17.2.11
SPATIAL GENOMICS
 
 
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
430
 
18.1
RESEARCH DATA
 
 
 
 
 
 
 
18.1.1
SECONDARY DATA
 
 
 
 
 
 
 
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
18.1.2
PRIMARY DATA
 
 
 
 
 
 
 
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
18.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
 
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
 
18.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
 
18.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
18.2.1
GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET ESTIMATION, 2025
 
 
 
 
 
 
18.2.2
SEGMENTAL MARKET SIZE ESTIMATION
 
 
 
 
 
18.3
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
 
18.4
DATA TRIANGULATION
 
 
 
 
 
 
18.5
FACTOR ANALYSIS
 
 
 
 
 
 
18.6
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
18.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
 
19
APPENDIX
 
 
 
 
 
443
 
19.1
DISCUSSION GUIDE
 
 
 
 
 
 
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
19.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
19.4
RELATED REPORTS
 
 
 
 
 
 
19.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INCLUSIONS AND EXCLUSIONS
 
 
 
 
 
 
TABLE 2
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
 
 
 
 
 
 
TABLE 3
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 4
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ROLE OF PLAYERS IN ECOSYSTEM
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 7
AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 8
IMPORT DATA FOR HS CODE 9027-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 9
EXPORT DATA FOR HS CODE 9027-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 10
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026–MARCH 2027
 
 
 
 
 
 
TABLE 11
US ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 12
CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES
 
 
 
 
 
 
TABLE 13
NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025
 
 
 
 
 
 
TABLE 14
LIST OF KEY PATENTS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2023-2025
 
 
 
 
 
 
TABLE 15
CASE STUDIES OF AI IMPLEMENTATION IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
 
 
 
 
 
 
TABLE 16
CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SPATIAL GENOMICS & TRANSCRIPTOMICS TECHNOLOGIES IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
 
 
 
 
 
 
TABLE 17
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 18
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 19
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 20
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 21
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INDUSTRY STANDARDS, BY COUNTRY
 
 
 
 
 
 
TABLE 22
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
 
 
TABLE 23
KEY BUYING CRITERIA, BY END USER (PRODUCT)
 
 
 
 
 
 
TABLE 24
KEY BUYING CRITERIA, BY END USER (SERVICES)
 
 
 
 
 
 
TABLE 25
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 26
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 27
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY VOLUME, 2023–2031(UNITS)
 
 
 
 
 
 
TABLE 38
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
IN SITU RNA SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
NORTH AMERICA: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
EUROPE: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
ASIA PACIFIC: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
LATIN AMERICA: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
NORTH AMERICA: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
EUROPE: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
ASIA PACIFIC: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
LATIN AMERICA: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
OTHER RNA SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
NORTH AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
EUROPE: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
ASIA PACIFIC: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
LATIN AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
SPATIAL GENOMICS PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
NORTH AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
EUROPE: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
ASIA PACIFIC: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
LATIN AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
NORTH AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
EUROPE: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
ASIA PACIFIC: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
LATIN AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
NORTH AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
EUROPE: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
ASIA PACIFIC: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
LATIN AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
EUROPE: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
EUROPE: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
EUROPE: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
EUROPE: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
EUROPE: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
US: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
US: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
CANADA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
CANADA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
GERMANY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
GERMANY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
UK: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
UK: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
FRANCE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
FRANCE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
ITALY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
ITALY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
SPAIN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
SPAIN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
CHINA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
CHINA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
JAPAN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
JAPAN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
INDIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
INDIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
MEXICO: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
MEXICO: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
AFRICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
AFRICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 525
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 526
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 527
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: OFFERING FOOTPRINT
 
 
 
 
 
 
TABLE 528
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TECHNIQUE FOOTPRINT
 
 
 
 
 
 
TABLE 529
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 530
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 531
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 532
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 533
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 534
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 535
10X GENOMICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 536
10X GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 537
10X GENOMICS: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 538
10X GENOMICS: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 539
10X GENOMICS: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 540
BIO-TECHNE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 541
BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 542
BIO-TECHNE: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 543
BIO-TECHNE: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 544
BRUKER: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 545
BRUKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 546
BRUKER: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 547
STANDARD BIOTOOLS INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 548
STANDARD BIOTOOLS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 549
STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 550
STANDARD BIOTOOLS INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 551
ILLUMINA, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 552
ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 553
ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 554
ILLUMINA, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 555
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 556
BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 557
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 558
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 559
VISIOPHARM A/S: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 560
VISIOPHARM A/S: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 561
VISIOPHARM A/S: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 562
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 563
DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 564
DANAHER CORPORATION: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 565
VELSERA INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 566
VELSERA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 567
REVVITY, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 568
REVVITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 569
REVVITY, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 570
VIZGEN, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 571
VIZGEN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 572
VIZGEN, INC.: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 573
VIZGEN, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 574
TAKARA HOLDINGS INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 575
TAKARA HOLDINGS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 576
TAKARA HOLDINGS INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 577
TAKARA HOLDINGS INC.: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 578
BGI GENOMICS CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 579
BGI: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 580
BGI: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 581
MACROGEN, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 582
MACROGEN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 583
MACROGEN, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 584
MACROGEN, INC.: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 585
MILTENYI BIOTEC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 586
MILTENYI BIOTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 587
MILTENYI BIOTEC: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 588
BIOMARKER TECHNOLOGIES (BMKGENE): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 589
PRECISION CELL SYSTEMS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 590
ADMERA HEALTH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 591
SONY BIOTECHNOLOGY INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 592
CANTATA BIO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 593
NUCLEAI, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 594
COMPLETE GENOMICS INCORPORATED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 595
BIOSPYDER, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 596
SINGULAR GENOMICS SYSTEMS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 597
REBUS BIOSYSTEMS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 598
SPATIAL GENOMICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 599
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
TABLE 600
RISK ASSESSMENT
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
REGIONS CONSIDERED
 
 
 
 
 
 
FIGURE 3
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 4
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 5
GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 6
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 7
DISRUPTIONS INFLUENCING GROWTH OF SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
 
 
 
 
 
 
FIGURE 8
HIGH-GROWTH SEGMENTS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 9
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
HIGH R&D INVESTMENTS AND INCREASED FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
 
 
 
 
 
 
FIGURE 11
PRODUCTS ACCOUNTED FOR LARGEST SHARE OF THE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET IN NORTH AMERICA IN 2025
 
 
 
 
 
 
FIGURE 12
ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET TILL 2031
 
 
 
 
 
 
FIGURE 13
TRANSLATIONAL RESEARCH TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 14
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 15
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 16
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 17
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 18
AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
FIGURE 19
AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
FIGURE 20
AVERAGE SELLING PRICE OF CONSUMABLES, BY REGION, 2025 (USD)
 
 
 
 
 
 
FIGURE 21
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 22
INVESTMENT AND FUNDING SCENARIO, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 23
PATENT APPLICATIONS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, JANUARY 2015-DECEMBER 2025
 
 
 
 
 
 
FIGURE 24
IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
 
 
 
 
 
 
FIGURE 25
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
 
 
FIGURE 26
KEY BUYING CRITERIA, BY END USER (PRODUCT)
 
 
 
 
 
 
FIGURE 27
KEY BUYING CRITERIA, BY END USER (SERVICES)
 
 
 
 
 
 
FIGURE 28
NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 29
ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 30
REVENUE ANALYSIS OF KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2021–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 31
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
 
 
 
 
 
 
FIGURE 32
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 33
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 34
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 35
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 36
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 37
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BRAND COMPARISON
 
 
 
 
 
 
FIGURE 38
10X GENOMICS: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 39
BIO-TECHNE: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 40
BRUKER: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 41
STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 42
ILLUMINA, INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 43
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 44
DANAHER CORPORATION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 45
REVVITY, INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 46
TAKARA HOLDINGS INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 47
BGI GENOMICS CO., LTD.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 48
MACROGEN, INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 49
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 50
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
FIGURE 51
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INSIGHTS FROM PRIMARIES
 
 
 
 
 
 
FIGURE 52
GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET ESTIMATION, 2025
 
 
 
 
 
 
FIGURE 53
SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025)
 
 
 
 
 
 
FIGURE 54
ILLUSTRATIVE EXAMPLE OF BIO-TECHNE: REVENUE ANALYSIS (2025)
 
 
 
 
 
 
FIGURE 55
SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 56
SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS
 
 
 
 
 
 
FIGURE 57
SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DATA TRIANGULATION
 
 
 
 
 
 

Methodology

This research study extensively utilized secondary sources, directories, and databases to identify and collect valuable information for analyzing the global spatial genomics & transcriptomics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size.

Secondary Research

Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the spatial genomics & transcriptomics market. The secondary sources referred to for this research study include publications from government sources, such as the World Health Organization (WHO), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), International Agency for Research on Cancer (IARC), Research!America, Genome Canada, GenomeWeb, South African Medical Research Council (SAMRC), Wellcome Sanger Institute, Genome Research Limited, Labiotech.eu, R&D World Magazine, India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, and Eurostat, among others.

Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements), business magazines and research journals, press releases, and trade, business, and professional associations. Secondary data was collected and analyzed to determine the overall size of the global market, which was validated through primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

Spatial Genomics and Transcriptomics Market
 Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate & validate the total size of the spatial genomics & transcriptomics market. These methods were also used extensively to estimate the size of various market segments.

Spatial Genomics and Transcriptomics Market Top Down and Bottom Up Approach

Data Triangulation

After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data were triangulated by analyzing various factors and trends from the demand and supply sides.

Market Definition

Spatial genomics and transcriptomics are pioneering technologies that allow scientists to measure gene activity in a tissue sample and map the site of the activity. Spatial transcriptomics helps spatially resolve RNA-seq data and all mRNAs in individual tissue sections. The technology is presently used in translational research and can be used in clinical diagnosis in the future. Spatial genomics also helps map gene expression across human tissues.

The scope of the market encompasses the tools, technologies, and services used to explore the spatial distribution and organization of genetic material and gene expression within cells and tissues.

Key Stakeholders

  • Manufacturers and distributors
  • Service providers
  • Pharmaceutical and biotechnology companies
  • Contract research organizations (CROs)
  • Contract development & manufacturing organizations (CDMOs)
  • Market research and consulting firms
  • R&D centers
  • Researchers and scientists
  • Academic & research institutes
  • Market research and consulting firms
  • Regulatory agencies
  • Venture capitalists
  • Government organizations
  • Industry associations and professional societies

Report Objectives

  • To define, describe, and forecast the spatial genomics & transcriptomics market based on offering, technique (products), type (services), application, end user (products), end user (services), and region, in terms of value
  • To forecast the size of the market segments concerning six main regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
  • To provide detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the market growth
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically profile the key players in the market and comprehensively analyze their core competencies and market rankings
  • To track and analyze competitive developments, such as product & service launches, acquisitions, expansions, agreements, partnerships, and collaborations, in the market
  • To benchmark players within the market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy

Available customizations:

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

  • Further breakdown of the Rest of Europe spatial genomics & transcriptomics market, by country
  • Further breakdown of the Rest of Asia Pacific spatial genomics & transcriptomics market, by country
  • Further breakdown of the Rest of Latin America spatial genomics & transcriptomics market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Spatial Genomics & Transcriptomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Spatial Genomics & Transcriptomics Market

THIS REPORT TELLS YOU

How big the Spatial Genomics & Transcriptomics market is, and who leads it.

GROWTHIQ TELLS YOU NEW

Where your company should play next, and who is taking your share.

Get your company's view of this market. Free snapshot.

DMCA.com Protection Status
popup img